BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 10.57 billion Indian Rupees [US$148.92 million]
of which 100%
Falco Holdings Co Ltd
(45.96 billion Japanese Yen [US$421.47 million]
of which 60%
was Medical Test), and
Miraca Holdings Incorporated
(195.40 billion Japanese Yen [US$1.79 billion]
of which 62%
was Clinical Examination).
BML Inc reported sales of ¥113.50 billion (US$1.04 billion)
March of 2018.
increase of 2.0%
versus 2017, when the company's sales were ¥111.24 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 20%).